Cabaletta Bio CABA Income Statement (2018-2026)

NASDAQ CABA
$1.45 +0.00 (+0.00%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

Cabaletta Bio Quarterly Income Statement

Periods 33 quarters
Latest Sep 2026

Cabaletta Bio reported net income of -$53.07M for the quarter ended Sep 2026. This income statement covers 33 quarters of results from Sep 2018 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating items
Research & DevelopmentR&D
9.92M9.17M9.51M8.22M12.40M12.44M11.80M13.79M17.41M21.95M23.43M26.29M25.53M29.02M37.64M39.82M36.19M37.35M44.43M47.14M
Selling, General & AdministrativeSG&A
3.97M3.83M3.55M3.56M3.90M4.52M4.09M4.88M5.74M6.08M6.85M6.76M8.25M8.12M8.27M6.76M6.42M6.94M7.59M7.56M
Other Operating ExpensesOther Opex
-0.06M0.50M-0.08M0.34M-0.08M0.02M
Operating ExpensesOpex
13.89M13.00M13.06M11.78M16.30M16.96M15.89M18.67M23.15M28.03M30.28M33.05M33.79M37.14M45.91M46.59M42.61M44.30M52.02M54.71M
Operating IncomeOp. Inc
-13.89M-13.00M-13.06M-11.78M-16.30M-16.96M-15.89M-18.67M-23.15M-28.03M-30.28M-33.05M-33.79M-37.14M-45.91M-46.59M-42.61M-44.30M-52.02M-54.71M
Non-operating items
Non Operating Interest Expenses
0.75M0.29M0.57M0.58M0.56M0.64M0.52M0.51M
Gains (Losses) on Sale of Assets & InvestmentsGains on Sales
0.01M-0.15M-0.10M0.04M0.16M0.05M0.00M-0.02M0.11M-0.08M0.01M0.03M0.00M0.00M0.02M0.00M-0.03M
Interest & Investment IncomeInt & Inv Inc
0.01M0.05M0.15M0.35M0.61M1.10M1.40M2.22M2.26M2.98M2.68M2.42M1.95M1.49M1.41M1.81M1.33M1.08M1.60M2.14M
Other Non Operating IncomeOther Non Op Inc.
-0.06M-0.08M
Net income details
EBIT
-13.89M-13.00M-13.06M-11.78M-16.30M-16.96M-15.89M-18.67M-23.15M-28.03M-30.28M-33.05M-33.79M-37.14M-45.91M-46.59M-42.61M-44.30M-52.02M-54.71M
EBT
-13.89M-12.95M-12.91M-11.43M-15.69M-15.85M-14.49M-16.45M-20.89M-25.05M-27.60M-30.63M-32.59M-35.94M-45.07M-45.36M-41.84M-43.86M-50.93M-53.07M
Income After Tax
-13.89M-12.95M-12.91M-11.43M-15.69M-15.85M-14.49M-16.45M-20.89M-25.05M-27.60M-30.63M-32.59M-35.94M-45.07M-45.36M-41.84M-43.86M-50.93M-53.07M
Income from Continuing OperationsIncome (Continuing)
-13.89M-12.95M-12.91M-11.43M-15.69M-15.85M-14.49M-16.45M-20.89M-25.05M-27.60M-30.63M-32.59M-35.94M-45.07M-45.36M-41.84M-43.86M-50.93M-53.07M
Consolidated Net IncomeConsol Net Inc.
-13.89M-12.95M-12.91M-11.43M-15.69M-15.85M-14.49M-16.45M-20.89M-25.05M-27.60M-30.63M-32.59M-35.94M-45.07M-45.36M-41.84M-43.86M-50.93M-53.07M
Income towards Parent CompanyParent Net Inc
-13.89M-12.95M-12.91M-11.43M-15.69M-15.85M-14.49M-16.45M-20.89M-25.05M-27.60M-30.63M-32.59M-35.94M-45.13M-44.87M-41.92M-43.52M-51.02M-53.05M
Preferred Dividend PaymentsPref Dividends
Net Income towards Common StockholdersNet Income
-13.89M-12.95M-12.91M-11.43M-15.69M-15.85M-14.49M-16.45M-20.89M-25.05M-27.60M-30.63M-32.59M-35.94M-45.13M-44.87M-41.92M-43.52M-51.02M-53.05M
Additional items
EPS (Basic)
-0.54-0.45-0.45-0.39-2.64-2.67-3.51-7.01-17.88-0.50-0.56-0.62-0.66-0.71-0.73-0.44-0.52-0.39-0.34-0.28
EPS (Diluted)
-0.46-0.39-0.40-0.35-0.48-0.42-0.35-0.36-0.49-0.49-0.55-0.62-0.65-0.71-0.73-0.44-0.41-0.39-0.34-0.28
Shares Outstanding
25.74M28.96M28.99M29.01M5.94M5.94M4.13M2.35M1.17M50.47M49.45M49.47M49.52M50.74M61.88M102.26M79.90M112.03M151.16M186.78M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
30.11M33.06M32.57M32.43M32.67M37.31M41.03M45.81M42.70M50.75M49.95M49.47M50.01M50.74M61.88M102.26M102.26M112.03M151.16M186.78M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
28.93M28.98M29.01M29.01M5.94M5.94M4.13M2.35M1.17M48.25M48.29M48.85M50.74M50.74M61.88M96.27M79.90M112.03M169.55M215.72M
EBITDA
-13.66M-12.83M-12.90M-11.47M-15.99M-16.60M-15.52M-18.31M-22.81M-27.64M-29.85M-32.62M-30.22M-35.19M-42.02M-42.76M-38.93M-39.94M-48.65M-51.13M
Interest ExpensesInt Expense
0.75M0.29M0.57M0.58M0.56M0.64M0.52M0.51M

Cabaletta Bio Income Statement API

Pull Cabaletta Bio's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CABA&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY